Resilience to expand global footprint, collaborating on first GMP biopharma facility in UAE

Published on January 19, 2023

National Resilience has secured an equity investment from Mubadala, an Abu Dhabi sovereign investor. The amount was not disclosed.

Continue reading on website
Other news

UK ATMP clinical research picture remains positive despite challenging global environment

January 19, 2023
In 2022, the UK continued to have a signficant footprint in ATMP clinical research, with total ongoing trials increasing from 168 in 2021 to 178 in 2022, according to a new report.

Eisai files marketing authorization applications for lecanemab in Europe and Japan

January 19, 2023
Eisai has submitted marketing authorization applications for lecanemab in Europe and Japan as it builds up its global plans for the Alzheimerâs drug, which was approved in the US earlier this month.